Cyr61 protein's effect on bone stem cells and age-related bone loss
Official title: Role of Cyr61/CCN1 in Mesenchymal Stem Cell Niche and Aging Bone
Funded at Rlr VA Medical Center · NIH-11264891 · Data updated 2026-11-12
This work tests whether restoring a protein called Cyr61 in the bone marrow environment can help bone stem cells respond better and support healthier bones in older adults.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rlr VA Medical Center NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project start | January 1, 2022 |
| Project end | December 31, 2026 |
| Funding year | 2026 |
| NIH project number | 5IK2BX005694-05 |
| Project ID | NIH-11264891 on NIH RePORTER |
Who could benefit from this research
✓Could help
Older adults with age-related bone loss, osteoporosis, or delayed fracture healing would be the most relevant group for eventual treatments based on this work.
✕Less likely to help
Young people with normal bone density or patients whose bone problems stem from unrelated causes (for example, some genetic disorders or certain medications) may not benefit from Cyr61-targeted approaches.
What this research studies
Researchers compare the support matrix made by bone marrow cells from young donors versus older donors to see how it affects mesenchymal stem cells (the cells that become bone). They found that older donors' matrix has less Cyr61 and that stem cells on older matrix respond poorly to a bone-growth signal called BMP-2. In the lab, removing Cyr61 from young matrix reduced stem cell responses, while adding Cyr61 back to old stromal cells restored BMP-2 responsiveness, and mouse studies link Cyr61 loss to lower bone density. The team uses cultured human bone marrow cells, gene delivery tools, and mouse models to understand whether fixing Cyr61-related changes could improve bone formation and healing.
Why it matters
Potential benefit: If successful, this could point to new therapies that restore bone stem cell function and improve bone density or fracture healing in older adults.
How similar studies have gone: Preclinical lab and mouse studies indicate Cyr61 affects bone formation and that restoring it can rescue stem cell responses, but human clinical benefits have not yet been demonstrated.
Where this research is happening
-
Rlr VA Medical Center
Indianapolis, United States Active
Researchers
- Principal investigator: Marinkovic, Milos — Rlr VA Medical Center
- Study coordinator: Marinkovic, Milos
Related research
Other NIH-funded projects on the same topics.
-
Aging Well with HIV: Alcohol, Risk Reduction, and Education Center (AWAR3E)
A center at Yale is exploring how aging with HIV interacts with alcohol use to create inflammation and frailty, with the goal of finding biomarkers and potential treatments.
-
Cognitive SuperAging: Exploring why some octogenarians stay sharp in memory
This NIH grant studies why a small group of people aged 80+ keep memory skills as good as much younger people, hoping to understand how to protect memory as we age.
-
Biological aging across the lifespan through a national high school-to-adult study
This grant uses a long-running national study of students and adults to collect saliva biomarkers of aging, alongside surveys, to understand how aging markers relate to health and life experiences.
-
Understanding how aging and Alzheimer’s affect how people make tough choices
This NIH grant studies how aging and Alzheimer’s risk change how people decide between immediate and delayed rewards and risky options, with the goal of helping older adults stay financially and healthwise safer.
-
Understanding how brain resilience and multiple brain pathologies influence aging and Alzheimer's disease
A long-term study follows older adults to learn how resilience to brain changes helps reduce dementia risk and what biological factors are linked to better cognitive aging.
-
National Neighborhood Data Archive helps researchers study aging health in U.S. neighborhoods
A nationwide data resource will help researchers understand how where people live affects health and aging, with a focus on respiratory illnesses in older adults.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.